Blood screening in the Americas gets $4.9 million boost:
This article was originally published in Clinica
The Bill and Melinda Gates Foundation has given $4.9 million to improve blood screening in the Americas over the next three years. The Pan American Health Organisation (PAHO) aims to improve laboratory services and set up quality assurance and performance evaluation programmes. Around 1.5 million units of blood are not screened for hepatitis C, while 50,000 units of blood are not screened for HIV and hepatitis B, according to PAHO. Around a dozen countries in Central and South America do not screen all donated blood for these viruses. PAHO also aims to promote screening of Chagas disease and syphilis.
You may also be interested in...
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.
Pfizer has revealed launch plans for its Nyvepria pegfilgrastim biosimilar, shortly after receiving formal European Commission approval.